Email RIS file
Bookmark
Report an Issue

Guidance for industry : NDA's : impurities in drug substances

Additional Titles
NDA's and Impurities in drug substances
Published
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2000]
Physical Description
1 electronic resource (3 unnumbered pages)
Additional Creators
Center for Drug Evaluation and Research (U.S.)
Access Online

Availability

I Want It
I Want It

Finding items...

Restrictions on Access
Free-to-read Unrestricted online access
Report Numbers
HE 20.4702:IM 7/6
Subject(s)
Note
"CMC."
"February 2000."
Action Note
committed to retain. Federal Depository Library Program (FDLP). For information on our retention commitment, please contact Microforms and Government Information.
View MARC record | catkey: 6194057